LTX-315 Recruiting Phase 2 Trials for Soft Tissue Sarcoma (STS) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03725605LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma